Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia
Mayo Clinic
Mayo Clinic
University of Washington
University of Washington
University of Chicago
The Lymphoma Academic Research Organisation
University of Washington
St. Jude Children's Research Hospital
M.D. Anderson Cancer Center
Dana-Farber Cancer Institute
Institute of Hematology & Blood Diseases Hospital, China
Ohio State University Comprehensive Cancer Center
Alliance for Clinical Trials in Oncology
Dana-Farber Cancer Institute
University of Washington
The Lymphoma Academic Research Organisation
M.D. Anderson Cancer Center
Goethe University
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
City of Hope Medical Center
Memorial Sloan Kettering Cancer Center
Fondazione Italiana Linfomi - ETS
N.N. Petrov National Medical Research Center of Oncology
Ohio State University Comprehensive Cancer Center
University of Washington
City of Hope Medical Center
Dana-Farber Cancer Institute
Abramson Cancer Center at Penn Medicine
University of Miami
City of Hope Medical Center
Baylor College of Medicine
Medical College of Wisconsin
Weill Medical College of Cornell University
City of Hope Medical Center
Ruijin Hospital
St. Jude Children's Research Hospital
City of Hope Medical Center
Shanghai Junshi Bioscience Co., Ltd.
New York Medical College
University of Miami
City of Hope Medical Center
International Extranodal Lymphoma Study Group (IELSG)
New York Medical College
Dana-Farber Cancer Institute
City of Hope Medical Center
City of Hope Medical Center
University of Miami
Ohio State University Comprehensive Cancer Center
Institute of Hematology & Blood Diseases Hospital, China